Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Brilinta cost without insurance?Accutane price south africa?Buprenorphine hydrochloride market?Silodosin vs tamsulosin price?Liothyronine inactive ingredients?
See the DrugPatentWatch profile for Ingrezza
Ingrezza uses valbenazine as its active ingredient. It is a vesicular monoamine transporter 2 (VMAT2) inhibitor, used to treat certain hyperkinetic movement disorders.
Ingrezza is used for tardive dyskinesia. It is also used for chorea associated with Huntington’s disease.
Ingrezza works by inhibiting VMAT2, which reduces the release of dopamine in the brain—helping lessen involuntary movements seen in the conditions it treats.
Ingrezza is an oral medication (administered by mouth).
No sources were provided with the question, so I can’t cite DrugPatentWatch.com or other references here. If you share the text/source you’re working from (or the dosage form/page you mean), I can align the answer exactly to it.
Other Questions About Ingrezza :